Cleopatra Hospital CoCAI:CLHO +3.66%88 Piotroski F-Score is 5 as of Jun. 25, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.81 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Cleopatra Hospital Co ranks better than 54.38% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Cleopatra Hospital Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Cleopatra Hospital Co's Piotroski F-Score or its related term are showing as below:
CAI:CLHO'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 5
During the past 11 years, the highest Piotroski F-Score of Cleopatra Hospital Co was 8. The lowest was 3. And the median was 6.
Cleopatra Hospital Co (CAI:CLHO) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Cleopatra Hospital Co Piotroski F-Score Related Terms
Cleopatra Hospital Co Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Cleopatra Hospital Co's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI:CLHO vs HCA, THC, DVA: Piotroski F-Score Comparison
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co Piotroski F-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Mar26) TTM:
Last Year (Mar25) TTM:
Net Income was 250.406 + 268.957 + 103.938 + 118.095 = E£741 Mil. Cash Flow from Operations was 399.492 + 771.963 + 187.965 + 529.582 = E£1,889 Mil. Revenue was 1763.487 + 1938.089 + 1907.03 + 1972.518 = E£7,581 Mil. Gross Profit was 695.126 + 774.835 + 774.244 + 644.588 = E£2,889 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(8779.726 + 9214.11 + 9978.216 + 10241.259 + 10984.689) / 5 = E£9839.6 Mil. Total Assets at the begining of this year (Mar25) was E£8,780 Mil. Long-Term Debt & Capital Lease Obligation was E£2,881 Mil. Total Current Assets was E£2,805 Mil. Total Current Liabilities was E£3,825 Mil.
Net Income was 142.962 + 207.206 + 190.948 + 200.58 = E£742 Mil.
Revenue was 1191.166 + 1459.746 + 1588.271 + 1618.658 = E£5,858 Mil. Gross Profit was 428.195 + 544.214 + 605.287 + 614.264 = E£2,192 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(5236.044 + 5678.657 + 6841.715 + 7589.753 + 8779.726) / 5 = E£6825.179 Mil. Total Assets at the begining of last year (Mar24) was E£5,236 Mil. Long-Term Debt & Capital Lease Obligation was E£2,344 Mil. Total Current Assets was E£2,722 Mil. Total Current Liabilities was E£2,869 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Cleopatra Hospital Co's current Net Income (TTM) was 741.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Cleopatra Hospital Co's current Cash Flow from Operations (TTM) was 1,889.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Cleopatra Hospital Co's return on assets of this year was 0.08444409. Cleopatra Hospital Co's return on assets of last year was 0.14165198.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Cleopatra Hospital Co's gearing of this year was 0.29283731. Cleopatra Hospital Co's gearing of last year was 0.3434181.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Cleopatra Hospital Co's current ratio of this year was 0.7333695. Cleopatra Hospital Co's current ratio of last year was 0.94875262.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Cleopatra Hospital Co's number of shares in issue this year was 1449.45. Cleopatra Hospital Co's number of shares in issue last year was 1443.808.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Cleopatra Hospital Co's gross margin of this year was 0.38105075. Cleopatra Hospital Co's gross margin of last year was 0.37419247.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Cleopatra Hospital Co's asset turnover of this year was 0.86348071. Cleopatra Hospital Co's asset turnover of last year was 1.1187532.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
0
+
0
+
1
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Cleopatra Hospital Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.
Cleopatra Hospital Co (CAI:CLHO) has a Piotroski F-Score of 5 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Cleopatra Hospital Co and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Cleopatra Hospital Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Cleopatra Hospital Co ranks #297 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 45.6%.
Is Cleopatra Hospital Co's Piotroski F-Score too high?
Cleopatra Hospital Co's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Cleopatra Hospital Co's value of 5 is 0% at this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #297 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #297 out of 651 companies for Piotroski F-Score. This puts Cleopatra Hospital Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Cleopatra Hospital Co's value of 5 is 0% at this benchmark. Historically, Cleopatra Hospital Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Cleopatra Hospital Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.81, compared to a current price of E£17.00 — trading 23.1% above its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current Piotroski F-Score is 5 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£17.00 is trading 23.1% above its estimated GF Value™ of E£13.81.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
GF Value™: E£13.81 vs. price of E£17.00 (23.1% above fair value)
Industry Position: 0% at the Healthcare Providers & Services median (#297 of 651)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score
Get the complete analysis for CAI:CLHO
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
